Improving liver cancer care for HIV patients in Uganda
Official title: Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study
Funded at Johns Hopkins University · NIH-11001696 · Data updated 2026-11-12
This study is looking to improve how we prevent and treat liver cancer for people living with HIV in Uganda by combining liver cancer care with their current HIV services, making it easier for patients to get the help they need.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 3, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $632,241 |
| NIH project number | 1U01CA275117-01A1 |
| Project ID | NIH-11001696 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults living with HIV in Uganda, particularly those at risk for hepatitis B co-infection.
✕Less likely to help
Patients who are not living with HIV or hepatitis B may not benefit from this research.
What this research studies
This research aims to enhance liver cancer control strategies by integrating them into existing HIV care services in Uganda. It focuses on understanding the co-infection of hepatitis B and HIV, and the resulting risks of liver cancer. The project will implement a comprehensive package of prevention, screening, and treatment interventions tailored to the local context, addressing barriers to care. By leveraging over 18 years of collaborative research, the study seeks to improve clinical management and outcomes for patients at risk of liver cancer.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence and mortality of liver cancer among HIV patients in Uganda.
How similar studies have gone: Previous research has shown success in integrating hepatitis B services into HIV care, indicating a promising approach for this study.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Kirk, Gregory D — Johns Hopkins University
- Study coordinator: Kirk, Gregory D
Related research
Other NIH-funded projects on the same topics.
-
AI-powered liver cancer screening using ultrasound blood flow patterns
A new AI-based method analyzes liver blood flow signals to help detect liver cancer early in people with liver disease, especially in settings with limited resources.
-
Aging and liver cancer: new ways to prevent and fight hepatocellular carcinoma
This research explores how aging promotes liver cancer and tests new preventive approaches that could help people at higher risk due to age.
-
Testing new therapies for pediatric and young adult sarcoma, kidney, and liver cancers
Researchers are testing new drugs and smart combinations in models of pediatric cancers to help guide future treatments for kids and young adults.
-
Liver cancer prevention and care in Uganda using HIV clinic networks
A program in Uganda uses existing HIV care systems to roll out liver cancer prevention, screening, and treatment strategies tailored to local needs.
-
Leveraging HIV care to prevent liver cancer in Uganda
A program in Uganda uses existing HIV care clinics to roll out a liver cancer prevention and treatment plan tailored to local needs.
-
Damaged telomeres and telomerase in liver scarring and liver cancer
Using human stem-cell models, researchers look at how short telomeres and telomerase changes can lead to liver scarring and liver cancer for people with telomere-related risks.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.